Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Capsule: SOP for Recordkeeping for Stability Studies of Capsules – V 2.0

Posted on By

Capsule: SOP for Recordkeeping for Stability Studies of Capsules – V 2.0

Standard Operating Procedure for Recordkeeping for Stability Studies of Capsules

Department Quality Control
SOP No. SOP/QC/222/2025
Supersedes SOP/QC/222/2022
Page No. Page 1 of 6
Issue Date 01/02/2025
Effective Date 05/02/2025
Review Date 01/02/2026

1. Purpose

The purpose of this SOP is to establish a procedure for recordkeeping of stability studies conducted on capsules. Accurate and detailed recordkeeping ensures that all stability testing data is preserved for regulatory compliance, traceability, and future use.

2. Scope

This SOP applies to all records generated during stability studies of capsules, including test data, analytical results, and packaging conditions. It covers the documentation, storage, and retrieval of stability study records at the facility.

3. Responsibilities

  • Quality Control (QC) Team: Responsible for conducting stability testing, documenting the results, and ensuring all data is accurately recorded.
  • Quality Assurance (QA) Team: Ensures that stability study records are maintained in compliance with regulatory requirements and company policies.
  • Records Management Team: Responsible for organizing and archiving stability study records, ensuring that they are easily accessible for audits and regulatory inspections.
  • Research and Development (R&D) Team: Provides input into stability study protocols and ensures that all required information is documented
throughout the study period.

4. Accountability

The QA Manager is responsible for overseeing the recordkeeping process and ensuring compliance with this SOP. The QC Manager is responsible for ensuring that stability study records are completed accurately and promptly.

5. Procedure

5.1 Planning and Initiating Stability Studies

Follow these steps when initiating stability studies:

  1. Define Stability Study Protocol

    1. Collaborate with the R&D team to develop a stability study protocol that includes the product details, study conditions (e.g., temperature, humidity), and time intervals for testing.
    2. Ensure that the study protocol includes all required testing parameters (e.g., dissolution, assay, appearance) and compliance with regulatory guidelines.
  2. Prepare Stability Study Records

    1. Prepare a stability study logbook or electronic record that will track all relevant data for the duration of the study.
    2. Record study start and end dates, testing conditions, and relevant identifiers (e.g., batch numbers, product codes).

5.2 Conducting Stability Tests

During the stability study, follow these steps for testing and documentation:

  1. Perform Stability Testing

    1. At each time interval specified in the study protocol, perform the required stability tests (e.g., dissolution, assay, pH, appearance).
    2. Ensure that testing is conducted according to the established methods and that all test parameters are documented.
  2. Document Test Results

    1. Record the results of all tests in the stability study logbook or electronic record.
    2. Ensure that results are clearly written or entered, including test conditions, test methods, and any deviations or anomalies observed during testing.

5.3 Review of Stability Data

Follow these steps for reviewing stability study data:

  1. Data Review by QC Team

    1. The QC team must review all stability test results for accuracy and compliance with the study protocol.
    2. Ensure that results are compared against the specifications set in the study protocol to determine if the capsules meet stability requirements.
  2. Approval by QA Team

    1. The QA team will review the stability study data, including test results and any observed deviations, to ensure compliance with GMP and regulatory standards.
    2. After review, QA will approve the stability study data for inclusion in the final report.

5.4 Final Stability Report and Archiving

Once the stability study is complete, follow these steps for reporting and archiving:

  1. Prepare Stability Study Report

    1. Prepare a final stability study report that includes all test results, observations, conclusions, and recommendations.
    2. The report should summarize the data obtained during the study and provide any necessary actions based on the results (e.g., product shelf life determination).
  2. Archive Stability Study Records

    1. All stability study records, including raw data, reports, and test results, should be archived in a secure location for future reference and regulatory inspections.
    2. Ensure that records are organized and easily retrievable based on batch number, product type, and study date.
  3. Retain Records for Required Period

    1. Stability study records should be retained for the duration required by regulatory guidelines (typically 5 years or as required by local regulations).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • CoA: Certificate of Analysis
  • BPR: Batch Packing Record

7. Documents

  1. Annexure 1: Stability Study Logbook Template
  2. Annexure 2: Stability Testing Protocol
  3. Annexure 3: Final Stability Study Report Template

8. References

  • Good Manufacturing Practice (GMP) Guidelines
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
  • ICH Q1A – Stability Testing of New Drug Substances and Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure 1: Stability Study Logbook Template

Batch Number Product Name Test Date Test Parameters Test Results Remarks
Batch 001 Capsule A 01/03/2025 Dissolution Pass Within specifications

Annexure 2: Stability Testing Protocol

Test Parameter Method Frequency Temperature Humidity
Dissolution USP Type 2 Apparatus Every 3 months 25°C 60%

Annexure 3: Final Stability Study Report Template

Batch Number Product Name Stability Period Conclusion Shelf Life
Batch 001 Capsule A 24 months Stable under prescribed conditions 36 months

12. Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial version of SOP Creation of SOP for stability study recordkeeping QA Head
01/02/2025 2.0 Updated stability testing methods and protocols Revised to incorporate updated testing standards QA Head
See also  Capsule: SOP for Shelf-Life Prediction Studies for Capsules - V 2.0
Capsules V 2.0 Tags:Active pharmaceutical ingredients (APIs) Capsule excipients, Capsule batch records, Capsule cleaning procedures, Capsule content uniformity, Capsule deviation management, Capsule disintegration testing, Capsule dissolution testing, Capsule filling process, Capsule inspection techniques, Capsule labeling requirements, Capsule maintenance protocols, Capsule Manufacturing, Capsule manufacturing equipment, Capsule packaging standards, Capsule process validation, Capsule production scheduling, Capsule Quality Control, Capsule regulatory compliance, Capsule safety guidelines, Capsule sealing methods, Capsule size specifications, Capsule stability testing, Capsule storage conditions, Capsule training programs, Empty capsule shells, Hard gelatin capsules, Pharmaceutical capsules, Soft gelatin capsules, Vegetarian capsules

Post navigation

Previous Post: API Manufacturing: SOP for Storage of Hazardous and Flammable Materials – V 2.0
Next Post: Tablets: SOP for Reviewing Blending and Granulation Records – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version